Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Clinical Impact of 18 f-FDG PET/CT As a Valuable Prognostic Tool for the Newly Diagnosed Multiple Myeloma with Extramedullary Disease

Dong Won Baek, MD, Hee Jeong Cho, Sang Kyun Sohn, MD PhD, Sung-Hoon Jung, MD, Hong chae Moon, Joon Ho Moon, MD

Blood (2019) 134 (Supplement_1): 3142.

https://doi.org/10.1182/blood-2019-129831

Published: 2019

Journal Articles

High Residual Allelic Burden Increases Leukemic Transformation Irrespective of Clinical Response in Patients with Lower Risk Myelodysplastic Syndrome Treated with Azacitidine

Joon Ho Moon, MD, Hee Jeong Cho, MD, Dong Won Baek, MD, Sang Kyun Sohn, MD PhD, Jae-Sook Ahn, Seo-Yeon Ahn, MD, Seunghyun Choi, PhD, Kyoung Ha Kim, MD PhD, Taehyung Kim, Zhaolei Zhang, PhD, Hyeoung-Joon Kim, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2019) 134 (Supplement_1): 4263.

https://doi.org/10.1182/blood-2019-130428

Published: 2019

Journal Articles

Identification of High Risk Group for Leukemic Transformation in Higher Risk MDS Patients Using Targeted RNA-Sequencing: Hematopoietic Stem Cell Signature As a High Risk Profile for Leukemic Transformation

Joon Ho Moon, MD, Taehyung Kim, MSc, Jae-Sook Ahn, MD PhD, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Yoojin Lee, MD PhD, Sang Kyun Sohn, MD PhD, Hyeoung-Joon Kim, MD PhD, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2018) 132 (Supplement 1): 4361.

https://doi.org/10.1182/blood-2018-99-116241

Published: 2018

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Severe Idiopathic Aplastic Anemia Older Than 40y

Hawk Kim, MD PhD, Yunsuk Choi, MD, Sung-Soo Yoon, MD PhD, Soo-Mee Bang, MD PhD, Hyeoung-Joon Kim, MD PhD, Sang Kyun Sohn, MD PhD, Yeung-Chul Mun, Young Rok Do, PhD MD, Yong Park, MD, Ji Hyun Lee, MD PhD, Sung Hwa Bae, MD, Ho Sup Lee, MD, Min Kyoung Kim, MD PhD, Won-Sik Lee, Jeong-Yeal Ahn, MD, Kyoo-Hyung Lee, MD PhD

Blood (2018) 132 (Supplement 1): 3876.

https://doi.org/10.1182/blood-2018-99-116190

Published: 2018

Journal Articles

RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, MD PhD, Marc S. Tyndel, B. Eng, Seung-Shin Lee, MD, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Ja-yeon Lee, MSc, Yoojin Lee, MDPhD, Sang Kyun Sohn, MD PhD, Zhaolei Zhang, PhD, Hyeoung-Joon Kim, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2018) 132 (Supplement 1): 2669.

https://doi.org/10.1182/blood-2018-99-112037

Published: 2018

Journal Articles

Pilot Prospective Phase II Study of Nilotinib Combined with Chemotherapy for Myeloid Blastic Phase of Chronic Myeloid Leukemia or Acute Myeloid Leukemia with BCR/ABL1

Hawk Kim, MD PhD, Yunsuk Choi, MD, Sung-Soo Yoon, MD PhD, Won-Sik Lee, Jee Hyun Kong, MD, Kyoo-Hyung Lee, MD PhD, Jeong-Yeal Ahn, MD, Sang Kyun Sohn, MD PhD

Blood (2018) 132 (Supplement 1): 3020.

https://doi.org/10.1182/blood-2018-99-116488

Published: 2018

Journal Articles

Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation

Yoo Jin Lee, MD, Joon Ho Moon, MD, PhD, In Hee Lee, MD, Jae-Ho Yoon, Byung-Sik Cho, Jae-Sook Ahn, MD PhD, Hyeoung Joon Kim, MD PhD, Silvia Park, Jun Ho Jang, MD PhD, Chul Won Jung, MD PhD, Hyunsung Park, MD, June-Won Cheong, MD, Je-Hwan Lee, MD PhD, Sang Kyun Sohn, MD, PhD, Hee-Je Kim

Blood (2016) 128 (22): 4566.

https://doi.org/10.1182/blood.V128.22.4566.4566

Published: 2016

Journal Articles

The Outcomes of Korean Patients with Primary Plasma Cell Leukemia: Analysis of Korean Multiple Myeloma Working Party (KMM160)

Sung-Hoon Jung, Je-Jung Lee, Kihyun Kim, MD PhD, Dok Hyun Yoon, Chang-Ki Min, Sang Kyun Sohn, MD, PhD, Chul Won Choi, Ho Sup Lee, Hyo Jung Kim, Ho-Jin Shin, MD PhD, Soo-Mee Bang, Sung-Soo Yoon, MD PhD, Seong Kyu Park, Ho-Young Yhim, Min Kyoung Kim, MD, Jae-Cheol Jo, MD PhD, Yeung-Chul Mun, Jae-Hoon Lee, Jin Seok Kim, MD PhD

Blood (2016) 128 (22): 4445.

https://doi.org/10.1182/blood.V128.22.4445.4445

Published: 2016

Journal Articles

Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome

Han-Seung Park, MD, Je-Hwan Lee, MD, Yoo-Jin Kim, Sang Kyun Sohn, MD, PhD, Sung-Soo Yoon, Hawk Kim, June-Won Cheong, MD, Won-Sik Lee, MD, Gyeong-Won Lee, MD, Young-Don Joo, MD, Min Kyoung Kim, MD, Yang Soo Kim, MD, Hyeoung-Joon Kim

Blood (2016) 128 (22): 1992.

https://doi.org/10.1182/blood.V128.22.1992.1992

Published: 2016

Journal Articles

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Blood (2016) 128 (22): 52.

https://doi.org/10.1182/blood.V128.22.52.52

Published: 2016

Journal Articles

RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis

Blood (2016) 128 (22): 5253.

https://doi.org/10.1182/blood.V128.22.5253.5253

Published: 2016

Journal Articles

The Clonal Origins of Leukemic Progression of Myelodysplasia

Taehyung Kim, MSc, Marc Tyndel, Hyeoung Joon Kim, MD, Jae-Sook Ahn, MD PhD, Seung Hyun Choi, PhD, Hee Jeong Park, Yeo-Kyeoung Kim, MD PhD, Deok-Hwan Yang, Je-Jung Lee, Sung-Hoon Jung, Soo Young Kim, Yoo-Hong Min, June-Won Cheong, MD, Sang Kyun Sohn, MD, PhD, Joon Ho Moon, MD, PhD, Murim Choi, Moses Lee, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 4307.

https://doi.org/10.1182/blood.V128.22.4307.4307

Published: 2016

Journal Articles

Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype

Blood (2016) 128 (22): 2876.

https://doi.org/10.1182/blood.V128.22.2876.2876

Published: 2016

Journal Articles

Efficacy of G-CSF Primed DLI Using Cells Reserved at the Time of Harvest in Patients with Hematologic Malignancies Who Lately Relapsed after Allogeneic PBSCT

YooJin Lee, MD, Joon Seok Yoon, In Hee Lee, MD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD, PhD

Blood (2016) 128 (22): 5809.

https://doi.org/10.1182/blood.V128.22.5809.5809

Published: 2016

Journal Articles

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Seung-Shin Lee, MD, Sung-Hoon Jung, MD PhD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, Park Hee Jeong, Seung Hyun Choi, PhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Heeje Kim, MD PhD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Sung-Hyun Kim, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 3832.

https://doi.org/10.1182/blood.V126.23.3832.3832

Published: 2015

Journal Articles

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Jun Ho Jang, Jin Seok Kim, MD PhD, Deog-Yeon Jo, MD PhD, Je-Hwan Lee, MD PhD, Chul Won Choi, MD PhD, Hyeoung Joon Kim, MD PhD, Jong-Ho Won, MD PhD, Joo Seop Chung, MD PhD, Hawk Kim, MD PhD, Jae-Hoon Lee, MD PhD, Sang Kyun Sohn, MD PhD, Jeong A Kim, MD PhD, Jong Wook Lee, MD PhD

Blood (2015) 126 (23): 4789.

https://doi.org/10.1182/blood.V126.23.4789.4789

Published: 2015

Journal Articles

Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group

Kyoung Ha Kim, Dae-Young Kim, MD PhD, Sung-Hyun Kim, Yeo-Kyeoung Kim, Inho Kim, Hee-Jin Kim, MD PhD, Sang Kyun Sohn, MD PhD, Jeon-Ok Lee, June-Won Cheong, MD, PhD, Chul Won Jung, MD PhD, Young-Uk Cho, MD PhD

Blood (2015) 126 (23): 5166.

https://doi.org/10.1182/blood.V126.23.5166.5166

Published: 2015

Journal Articles

Efficacy of Nilotinib Vs High-Dose Imatinib Vs Sustaining Standard-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Response to Frontline Imatinib

Soo Young Choi, Sung-Eun Lee, Yun jeong Oh, Soo-Hyun Kim, Richard C. Woodman, Tomasz Szczudlo, MD, Saengsuree Jootar, MD, Hyeoung-Joon Kim, MD PhD, Sang Kyun Sohn, MD PhD, Joon Seong Park, MD, Sung-Hyun Kim, MD PhD, Dae-Young Zang, Suk-Joong Oh, Dong-Wook Kim, MD PhD

Blood (2014) 124 (21): 1816.

https://doi.org/10.1182/blood.V124.21.1816.1816

Published: 2014

Journal Articles

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Il-Kwon Lee, PhD, Nan Young Kim, Mark D Minden, MDPhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Hee-Je Kim, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Jong-Ho Won, Sung-Hyun Kim, MD PhD, Namshin Kim, PhD, Kenichi Yoshida, MD PhD, Seishi Ogawa, MD PhD, Dennis Dong Hwan Kim, MDPhD

Blood (2014) 124 (21): 1052.

https://doi.org/10.1182/blood.V124.21.1052.1052

Published: 2014

Journal Articles

Similar Levels of Complement Activation in Both Patients with Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome: The Report from the Korean TTP Registry

Blood (2014) 124 (21): 4195.

https://doi.org/10.1182/blood.V124.21.4195.4195

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Clinical Impact of 18 f-FDG PET/CT As a Valuable Prognostic Tool for the Newly Diagnosed Multiple Myeloma with Extramedullary Disease

High Residual Allelic Burden Increases Leukemic Transformation Irrespective of Clinical Response in Patients with Lower Risk Myelodysplastic Syndrome Treated with Azacitidine

Identification of High Risk Group for Leukemic Transformation in Higher Risk MDS Patients Using Targeted RNA-Sequencing: Hematopoietic Stem Cell Signature As a High Risk Profile for Leukemic Transformation

Allogeneic Hematopoietic Cell Transplantation for Severe Idiopathic Aplastic Anemia Older Than 40y

RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Pilot Prospective Phase II Study of Nilotinib Combined with Chemotherapy for Myeloid Blastic Phase of Chronic Myeloid Leukemia or Acute Myeloid Leukemia with BCR/ABL1

Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation

The Outcomes of Korean Patients with Primary Plasma Cell Leukemia: Analysis of Korean Multiple Myeloma Working Party (KMM160)

Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis

The Clonal Origins of Leukemic Progression of Myelodysplasia

Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype

Efficacy of G-CSF Primed DLI Using Cells Reserved at the Time of Harvest in Patients with Hematologic Malignancies Who Lately Relapsed after Allogeneic PBSCT

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group

Efficacy of Nilotinib Vs High-Dose Imatinib Vs Sustaining Standard-Dose Imatinib in Early Chronic Phase CML Patients Who Have Suboptimal Molecular Response to Frontline Imatinib

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

Similar Levels of Complement Activation in Both Patients with Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome: The Report from the Korean TTP Registry

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only